160 related articles for article (PubMed ID: 28194917)
21. Immunological and angiogenic markers during metronomic temozolomide and cyclophosphamide in canine cancer patients.
Denies S; Cicchelero L; de Rooster H; Daminet S; Polis I; Van de Maele I; Sanders NN
Vet Comp Oncol; 2017 Jun; 15(2):594-605. PubMed ID: 26961119
[TBL] [Abstract][Full Text] [Related]
22. Clinical and immunomodulatory effects of toceranib combined with low-dose cyclophosphamide in dogs with cancer.
Mitchell L; Thamm DH; Biller BJ
J Vet Intern Med; 2012; 26(2):355-62. PubMed ID: 22303814
[TBL] [Abstract][Full Text] [Related]
23. Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide.
Polton G; Finotello R; Sabattini S; Rossi F; Laganga P; Vasconi ME; Barbanera A; Stiborova K; Rohrer Bley C; Marconato L
Vet Comp Oncol; 2018 Sep; 16(3):399-408. PubMed ID: 29508493
[TBL] [Abstract][Full Text] [Related]
24. Cyclophosphamide-induced cystitis in the dog and cat.
Crow SE; Theilen GH; Madewell BR; Weller RE; Henness AM
J Am Vet Med Assoc; 1977 Aug; 171(3):259-62. PubMed ID: 893208
[No Abstract] [Full Text] [Related]
25. High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors.
Spugnini EP; Buglioni S; Carocci F; Francesco M; Vincenzi B; Fanciulli M; Fais S
J Transl Med; 2014 Aug; 12():225. PubMed ID: 25143012
[TBL] [Abstract][Full Text] [Related]
26. Tolerability of lomustine in combination with cyclophosphamide in dogs with lymphoma.
Rassnick KM; Bailey DB; Malone EK; Flory AB; Kiselow MA; Intile JL
J Am Anim Hosp Assoc; 2014; 50(3):167-73. PubMed ID: 24659727
[TBL] [Abstract][Full Text] [Related]
27. Hemorrhagic cystitis in a dog.
Marin MP; Samson RJ; Jackson ER
Can Vet J; 1996 Apr; 37(4):240. PubMed ID: 8801023
[No Abstract] [Full Text] [Related]
28. Immunological, anti-angiogenic and clinical effects of intratumoral interleukin 12 electrogene therapy combined with metronomic cyclophosphamide in dogs with spontaneous cancer: A pilot study.
Cicchelero L; Denies S; Vanderperren K; Stock E; Van Brantegem L; de Rooster H; Sanders NN
Cancer Lett; 2017 Aug; 400():205-218. PubMed ID: 27693635
[TBL] [Abstract][Full Text] [Related]
29. Urinary elimination of cyclophosphamide alkylating metabolites and free thiols following two administration schedules of high-dose cyclophosphamide and mesna.
Fleming RA; Cruz JM; Webb CD; Kucera GL; Perry JJ; Hurd DD
Bone Marrow Transplant; 1996 Apr; 17(4):497-501. PubMed ID: 8722345
[TBL] [Abstract][Full Text] [Related]
30. Tolerability of metronomic administration of lomustine in dogs with cancer.
Tripp CD; Fidel J; Anderson CL; Patrick M; Pratt C; Sellon R; Bryan JN
J Vet Intern Med; 2011; 25(2):278-84. PubMed ID: 21314727
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of low-dose metronomic (LDM) cyclophosphamide toxicity in cats with malignant neoplasia.
Leo C; Stell A; Borrego J; Martinez de Merlo E; Ruess-Melzer K; Lara-Garcia A
J Feline Med Surg; 2014 Aug; 16(8):671-8. PubMed ID: 24423814
[TBL] [Abstract][Full Text] [Related]
32. The addition of metronomic chemotherapy does not improve outcome for canine splenic haemangiosarcoma.
Alexander CK; Cronin KL; Silver M; Gardner HL; London C
J Small Anim Pract; 2019 Jan; 60(1):32-37. PubMed ID: 30209807
[TBL] [Abstract][Full Text] [Related]
33. Cyclophosphamide-based metronomic chemotherapy: after 10 years of experience, where do we stand and where are we going?
Penel N; Adenis A; Bocci G
Crit Rev Oncol Hematol; 2012 Apr; 82(1):40-50. PubMed ID: 21641231
[TBL] [Abstract][Full Text] [Related]
34. Low-dose cyclophosphamide associated with hemorrhagic cystitis in a breast cancer patient.
Marshall A; McGrath C; Torigian D; Papanicolaou N; Lal P; Kaplan Tweed C
Breast J; 2012; 18(3):272-5. PubMed ID: 21972971
[TBL] [Abstract][Full Text] [Related]
35. Prospective trial of metronomic chlorambucil chemotherapy in dogs with naturally occurring cancer.
Leach TN; Childress MO; Greene SN; Mohamed AS; Moore GE; Schrempp DR; Lahrman SR; Knapp DW
Vet Comp Oncol; 2012 Jun; 10(2):102-12. PubMed ID: 22236329
[TBL] [Abstract][Full Text] [Related]
36. Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma.
Gebbia V; Boussen H; Valerio MR
Anticancer Res; 2012 Feb; 32(2):529-36. PubMed ID: 22287742
[TBL] [Abstract][Full Text] [Related]
37. [Long-term oral low-dose cyclophosphamide-induced hemorragic cystitis which was successfully treated by ureterostomy: a case report].
Takagi K; Kojima K; Yuhara K; Shibata Y
Hinyokika Kiyo; 2012 Dec; 58(12):687-90. PubMed ID: 23328165
[TBL] [Abstract][Full Text] [Related]
38. [Hemorrhagic cystitis after high dose chemotherapy. An interdisciplinary problem].
Sommerkamp H
Urologe A; 1998 Sep; 37(5):516-21. PubMed ID: 9796033
[TBL] [Abstract][Full Text] [Related]
39. Safety and cost of hyperhydration for the prevention of hemorrhagic cystitis in bone marrow transplant recipients.
Ballen KK; Becker P; Levebvre K; Emmons R; Lee K; Levy W; Stewart FM; Quesenberry P; Lowry P
Oncology; 1999 Nov; 57(4):287-92. PubMed ID: 10575313
[TBL] [Abstract][Full Text] [Related]
40. Hyperbaric oxygenation therapy for cyclophosphamide-induced haemorrhagic cystitis.
Yazawa H; Nakada T; Sasagawa I; Miura M; Kubota Y
Int Urol Nephrol; 1995; 27(4):381-5. PubMed ID: 8586509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
